VYNE Therapeutics Inc
|Market Cap (Intraday)||13.59M|
|2yr Forward PE||N/A|
VYNE Therapeutics Inc Stock, NASDAQ:VYNE
VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercialize solutions using its proprietary Molecule Stabilizing Technology. Its commercial products include AMZEEQ and ZILXI. The company was founded on October 21, and is headquartered in Bridgewater, NJ.